FDA Criticized For Delay Pulling Drug that is linked to death_CBS News, April 27, 2000.

The following report by CBS News about the sudden death of a baby

(Gage Stevens), who was diagnosed with reflux (a stomach acid problem),but was

prescribed Propulsid as an experimental subject in an FDA approved study--

even though "Propulsid had been linked to dozens of adult heart deaths."

According to CBS News, "The study consent form made no mention of any deaths

associated with the drug under the heading of "risks and benefits." "Propulsid doesn't treat a life-threatening condition, there's no reason to let patients keep taking it and risk more deaths," said an FDA source.

[FB—here again, the public fails to understand the elements of their right of informed consent and the risk/benefit analysis that is at it’s heart. Of the sudden death of baby, Gage Stevens, it was said "Propulsid doesn't treat a life-threatening condition, there's no reason to let patients keep taking it and risk more deaths." Here it is understood that a mild physical condition (acid reflux) is to be found on the risk side of the risk/benefit equation but that this cannot justify the use of Propulsid, which bears more potential for risk than benefit. But, to this day, the public fails to understand that in the use of psychiatric drugs, the psychiatric ‘disorders’/ ‘diseases’ on the risk side of the equation are not diseases at all having confirmatory physical abnormalities but are a sham, a fraud, nothing more than illusions of diseases. The only physical risks in treatment with psychiatric drugs are those from the drugs themselves.]